TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
NVCR

Novocure Ltd

Healthcare · Medical Devices

15.80$ -2.2% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow NVCR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-479.3% -301.9% -129.8% -18.7% -0.8% 7.6% 20.1% 15.5% 5.7% -14.4% -4.4% -7.5%
12.7% 9.5% 6.8% 4.3% 3.6% 2.4% 1.9% 1.9% 2.0% 2.2% -2.4% 2.2%
29.9% 35.8% 26.7% 15.3% 16.1% 14.9% 15.3% 17.7% 19.9% 22.7% 26.4% 16.0%
29.9% 36.0% 33.0% 15.0% 16.2% 14.8% 15.3% 19.0% 19.5% – – –
-1.0% -13.2% -11.4% -3.8% 4.6% -6.9% -1.7% 5.4% 2.2% 5.8% -0.7% -2.3%
15.0% 31.0% 21.3% 4.2% 2.7% 3.0% 3.0% 4.5% 4.0% 5.3% 7.1% 4.1%
-298.1% -348.5% 15.5% 3.8% -2.2% -14.7% -95.6% -27.1% -26.0% 36.2% -23.2% 66.7%
– 0.0% 0.0% 0.0% – – – – – – – –
13.9% 0.0% 1.9% 3.0% 8.2% 17.6% 6.4% 4.8% 2.9% – – –
-0.1% 69.0% 87.8% 0.0% 19.8% 0.0% 82.6% 0.0% 0.0% 0.0% 13.9% -70.3%
13.8% 837.2% 90.6% 2.9% 28.0% 17.6% 89.0% 4.8% 2.9% 3.1% 14.9% -68.9%
-763.6% 186.8% -23.7% -12.0% 25.0% 10.4% 13.5% -6.8% -17.4% 24.9% -12.6% -9.6%
-494.3% -332.9% -151.1% -22.9% -3.5% 4.6% 17.0% 11.0% 1.8% -19.7% -11.4% -11.5%

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?